HUP0102929A2 - Levozimendan alkalmazása pulmonáris hipertenzió kezelésére alkalmas gyógyszerkészítmény előállítására - Google Patents

Levozimendan alkalmazása pulmonáris hipertenzió kezelésére alkalmas gyógyszerkészítmény előállítására

Info

Publication number
HUP0102929A2
HUP0102929A2 HU0102929A HUP0102929A HUP0102929A2 HU P0102929 A2 HUP0102929 A2 HU P0102929A2 HU 0102929 A HU0102929 A HU 0102929A HU P0102929 A HUP0102929 A HU P0102929A HU P0102929 A2 HUP0102929 A2 HU P0102929A2
Authority
HU
Hungary
Prior art keywords
treatment
pulmonary hypertension
levosimendan
medicament
manufacture
Prior art date
Application number
HU0102929A
Other languages
English (en)
Inventor
Lasse Lehtonen
Original Assignee
Orion Corp.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp. filed Critical Orion Corp.
Publication of HUP0102929A2 publication Critical patent/HUP0102929A2/hu
Publication of HUP0102929A3 publication Critical patent/HUP0102929A3/hu
Publication of HU226021B1 publication Critical patent/HU226021B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)

Abstract

A tal lm ny t rgya (-)-[[4-(1,4,5,6-tetrahidro-4-metil-6-oxo-3-piridazinil)-fenil]-hidrazino]-prop ndinitril vagy gyógyszerészetilegelfogadható sója alkalmaz sa pulmon ris hipertenzió kezelésérealkalmas gyógyszerkészítmény elő llít s ra. Ó
HU0102929A 1998-06-25 1999-06-18 Use of levosimendan in the manufacture of a medicament for the treatment of pulmonary hypertension HU226021B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI981473A FI981473A (fi) 1998-06-25 1998-06-25 Menetelmä pulmonaalihypertension hoitamiseksi
PCT/FI1999/000540 WO1999066912A2 (en) 1998-06-25 1999-06-18 Method of treating pulmonary hypertension

Publications (3)

Publication Number Publication Date
HUP0102929A2 true HUP0102929A2 (hu) 2002-04-29
HUP0102929A3 HUP0102929A3 (en) 2002-07-29
HU226021B1 HU226021B1 (en) 2008-03-28

Family

ID=8552079

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0102929A HU226021B1 (en) 1998-06-25 1999-06-18 Use of levosimendan in the manufacture of a medicament for the treatment of pulmonary hypertension

Country Status (24)

Country Link
US (1) US6462045B1 (hu)
EP (1) EP1089737B1 (hu)
JP (1) JP4536922B2 (hu)
KR (1) KR100661769B1 (hu)
AT (1) ATE226076T1 (hu)
AU (1) AU748883B2 (hu)
BR (1) BR9911422A (hu)
CA (1) CA2335280C (hu)
CZ (1) CZ300844B6 (hu)
DE (1) DE69903546T2 (hu)
DK (1) DK1089737T3 (hu)
EA (1) EA003055B1 (hu)
EE (1) EE04355B1 (hu)
ES (1) ES2186375T3 (hu)
FI (1) FI981473A (hu)
HU (1) HU226021B1 (hu)
MX (1) MXPA00012618A (hu)
NO (1) NO317593B1 (hu)
NZ (1) NZ508833A (hu)
PL (1) PL193055B1 (hu)
PT (1) PT1089737E (hu)
SK (1) SK284581B6 (hu)
WO (1) WO1999066912A2 (hu)
ZA (1) ZA200007462B (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20001542A (fi) * 2000-06-29 2001-12-30 Orion Yhtymae Oyj Menetelmä septisen sokin hoitamiseksi
FI20002755A0 (fi) 2000-12-15 2000-12-15 Orion Yhtymae Oyj Menetelmä erektiilin dysfunktion hoitamiseen
FI20010233A0 (fi) 2001-02-08 2001-02-08 Orion Corp Menetelmä sydämen vajaatoiminnan hoitoon
FI20040675A0 (fi) * 2004-05-12 2004-05-12 Orion Corp Menetelmä sydämen hypertrofian hoitoon ja estoon
WO2006087420A2 (en) * 2005-02-18 2006-08-24 Orion Corporation A method for treating heart failure
CA3161960A1 (en) 2019-12-16 2021-06-24 Tenax Therapeutics, Inc. Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (ph-hfpef)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0302595B1 (en) * 1987-07-07 1994-02-02 Beecham Group Plc Pinacidil for treatment of pulmonary hypertension or right heart failure
GB2251615B (en) * 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
RO113612B1 (ro) * 1991-04-17 1998-09-30 Merck & Co Inc Compozitie oftalmica
GB2266841A (en) 1992-05-06 1993-11-17 Orion Yhtymae Oy Compounds for use as anti-ischemic medicaments
GB9614098D0 (en) * 1996-07-05 1996-09-04 Orion Yhtymae Oy Transdermal delivery of levosimendan

Also Published As

Publication number Publication date
EE200000775A (et) 2002-04-15
NO317593B1 (no) 2004-11-15
JP2002518436A (ja) 2002-06-25
DE69903546T2 (de) 2003-06-18
BR9911422A (pt) 2001-03-13
EA003055B1 (ru) 2002-12-26
AU748883B2 (en) 2002-06-13
ZA200007462B (en) 2002-03-13
CA2335280A1 (en) 1999-12-29
KR20010072640A (ko) 2001-07-31
SK284581B6 (sk) 2005-07-01
DE69903546D1 (de) 2002-11-21
HU226021B1 (en) 2008-03-28
FI981473A (fi) 1999-12-26
DK1089737T3 (da) 2003-02-10
NO20006652D0 (no) 2000-12-22
MXPA00012618A (es) 2005-06-06
FI981473A0 (fi) 1998-06-25
PL193055B1 (pl) 2007-01-31
EE04355B1 (et) 2004-10-15
NZ508833A (en) 2002-10-25
PL345467A1 (en) 2001-12-17
US6462045B1 (en) 2002-10-08
ATE226076T1 (de) 2002-11-15
CA2335280C (en) 2007-10-30
SK19252000A3 (sk) 2002-04-04
HUP0102929A3 (en) 2002-07-29
ES2186375T3 (es) 2003-05-01
EA200100074A1 (ru) 2001-06-25
JP4536922B2 (ja) 2010-09-01
NO20006652L (no) 2000-12-22
EP1089737B1 (en) 2002-10-16
KR100661769B1 (ko) 2006-12-28
EP1089737A2 (en) 2001-04-11
AU4786499A (en) 2000-01-10
CZ20004663A3 (en) 2001-05-16
WO1999066912A2 (en) 1999-12-29
PT1089737E (pt) 2003-03-31
WO1999066912A3 (en) 2000-03-16
CZ300844B6 (cs) 2009-08-26

Similar Documents

Publication Publication Date Title
DE69201640D1 (de) (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]-hydrazono]propandinitril.
NO952309D0 (no) Anvendelse av riluzol ved behandling av Parkinsons sykdom og Parkinsonske syndromer
IL165264A (en) Protein kinase inhibitors, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for treating protein kinase-associated diseases
TW237452B (hu)
WO2002000209A3 (en) Gabapentin analogues for sleep disorders
MX9701329A (es) Metodos para la inhibicion de la replicacion viral.
ATE196086T1 (de) Anti-ischaemisches arzneimittel
CY1107616T1 (el) Καινοτομος χρηση της 2-[5-(4-φθοροφαινυλο)-3-πυριδυλομεθυλαμινομεθυλο]-χρωμανης και των φυσιολογικα αποδεκτων αλατων της
HUP0102929A2 (hu) Levozimendan alkalmazása pulmonáris hipertenzió kezelésére alkalmas gyógyszerkészítmény előállítására
NO981856L (no) Anvendelse av 1-(2-naft-2-yletyl)-4-(3-trifluormetylfenyl)-1,2,3,6-tetrahydropyridin for fremstilling av legemidler for behandling av amyotrof lateral sclerose
NO994257D0 (no) Anvendelse av levobupivakain ved ansiktskirurgi
HUP0300298A2 (hu) 4-[Piperazinil-8-(kinolinil-metil)]benzamid-származékok, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
NZ513851A (en) Use of saredutant and the pharmaceutically acceptable salts thereof to produce medicaments used to treat or prevent mood disorders, adjustment disorders or mixed anxiety-depression disorders
HUP0300863A2 (hu) N-(3,5-diklór-2-metoxi-fenil)-4-metoxi-3-(1-piperazinil)-benzolszulfonamid, eljárás elżállítására és a vegyületet tartalmazó gyógyszerkészítmény
FI956269A (fi) Ropivakaiinin käyttö kipua lievittävän vaikutuksen omaavan ja häviävän vähäisen motoriikan estymisen aikaansaavan farmaseuttisen tuotteen valmistukseen
BR0109119A (pt) Uso de (r)-(-)-2-[5-(4-fluorofenil)-3-piridilmetil-aminometil]-cr omano e seus sais fisiologicamente aceitáveis
HUP0402654A2 (hu) 2-[(2'-Halogén-3',5'-dialkoxi-fenil)-imino]-imidazolidin-származékok, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények
HUP0203161A2 (hu) Benzamidinszármazékok, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
NZ543709A (en) Use of tyrosine kinase inhibitor to treat diabetes
AU7928700A (en) A new use of levosimendan
NO20010984D0 (no) Anvendelse av R(+)-<alfa>-(2,3-dimetoksyfenyl)-1-[2-(4- fluorfenyl)etyl]-4-piperidinmetanol for behandling av søvnforstyrrelser
NO974840L (no) Ny form av (E)-3-[6-[[(2,6-diklorfenyl)-tio]metyl]-3-(2-fenyletoksy)-2-pyridinyl]-2-propensyre

Legal Events

Date Code Title Description
HC9A Change of name, address

Owner name: ORION CORPORATION ID NO.1999212-6, FI

Free format text: FORMER OWNER(S): ORION CORP., FI

MM4A Lapse of definitive patent protection due to non-payment of fees